These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 29021832)

  • 1. Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.
    Amare AT; Schubert KO; Baune BT
    EPMA J; 2017 Sep; 8(3):211-227. PubMed ID: 29021832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.
    Le-Niculescu H; Roseberry K; Gill SS; Levey DF; Phalen PL; Mullen J; Williams A; Bhairo S; Voegtline T; Davis H; Shekhar A; Kurian SM; Niculescu AB
    Mol Psychiatry; 2021 Jul; 26(7):2776-2804. PubMed ID: 33828235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted proteomic analysis of cognitive dysfunction in remitted major depressive disorder: Opportunities of multi-omics approaches towards predictive, preventive, and personalized psychiatry.
    Schubert KO; Stacey D; Arentz G; Clark SR; Air T; Hoffmann P; Baune BT
    J Proteomics; 2018 Sep; 188():63-70. PubMed ID: 29474866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical multi-omics strategies for the effective cancer management.
    Yoo BC; Kim KH; Woo SM; Myung JK
    J Proteomics; 2018 Sep; 188():97-106. PubMed ID: 28821459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized medicine in Alzheimer's disease and depression.
    Souslova T; Marple TC; Spiekerman AM; Mohammad AA
    Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
    Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
    Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and Future Prospects of Precision Medicine in Psychiatry.
    Manchia M; Pisanu C; Squassina A; Carpiniello B
    Pharmgenomics Pers Med; 2020; 13():127-140. PubMed ID: 32425581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern recognition for predictive, preventive, and personalized medicine in cancer.
    Cheng T; Zhan X
    EPMA J; 2017 Mar; 8(1):51-60. PubMed ID: 28620443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular pathophysiology of mood disorders: From the analysis of single molecular layers to multi-omic integration.
    Mokhtari A; Porte B; Belzeaux R; Etain B; Ibrahim EC; Marie-Claire C; Lutz PE; Delahaye-Duriez A
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110520. PubMed ID: 35104608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic Characterization in Bipolar Spectrum Disorders.
    Fortinguerra S; Sorrenti V; Giusti P; Zusso M; Buriani A
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
    Pisanu C; Heilbronner U; Squassina A
    Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
    Ahmed Z
    Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker-Guided Tailored Therapy.
    Lydiard J; Nemeroff CB
    Adv Exp Med Biol; 2019; 1192():199-224. PubMed ID: 31705496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic aspects of bipolar disorder: An update.
    Budde M; Degner D; Brockmöller J; Schulze TG
    Eur Neuropsychopharmacol; 2017 Jun; 27(6):599-609. PubMed ID: 28342679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.